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Hereditary hemochromatosis (HH) is the most common genetic disorder occurring in
individuals of northern European descent. The clinical characteristic of this disease is
the gradual accumulation of iron in internal organs, which ultimately leads to organ
failure and death. The defective gene in the majority of cases, HFE, was identified in
1996. Three allelic variants of the HFE gene have been correlated with HH: C282Y is
significantly associated with HH; H63D and S65C have unclear relationships. In this
report, these mutations were analyzed in 8 patients with HH and in 148 healthy individuals
(blood donors). To detect the mutations, exons 2 and 4 of the HFE gene were amplified
by PCR followed by restriction endonucleases cleavage. In patients with HH, three
individuals were homozygous for the C282Y mutation, one showed compound
heterozygous (C282Y/H63D), one was heterozygous for the C282Y and 3 presented
with no mutations. In healthy individuals, the allele frequency observed was 0.014 for
C282Y, 0.108 for H63D and 0.010 for S65C. The frequency of mutations was significantly
higher in Caucasians compared with non-Caucasians. These data are concordant with
the previous literature and with the ethnical origin of the population studied.   Rev. bras.
hematol. hemoter. 2006;28(4):293-295.
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Hereditary hemochromatosis (HH) is an iron metabolism
disorder characterized by increased iron absorption. Iron is
progressively deposited in various tissues, particularly in
the liver, pancreas, heart, joints and pituitary gland.1
Phenotypic expression and severity of HH are variable and
appear to depend on a complex interaction of genetic defect,
age, gender and such environmental influences as dietary
iron, the extent of iron loss from other processes, and the
presence of other diseases and toxins (e.g., alcohol).2 This
inherited iron metabolism disorder is one of the most common
genetic diseases in northern European descendents, affecting
one in every 200-300 individuals.3
The gene responsible for HH was discovered in 1996
by Feder et al.4 who described the novel gene and two sense
mutations, C282Y and H63D.2,5 The most important molecular
mutation associated to clinical features, C282Y, has different
frequencies in different populations. For example, the
frequency of this mutation in Australian HH patients is 100%
and in Italian HH patients it is 64%.6 The other implicated
mutation, H63D, does not seem to have such a strong
association to iron overload, although the heterozygous
C282Y/H63D is responsible for about 6% of HH cases in
Europe and 4% in the USA.6
To date, 37 allelic variants of the HFE gene have been
reported, but, except for C282Y and H63D, only S65C has
been implicated in a moderate form of HH.2 This mutation is
observed in 2-3% of Caucasians and initially, it was
considered to be a neutral polymorphism. Recent reports
however, have implicated this mutation in mild iron overload
when inherited in the compound heterozygous state.6-8
There are few reports in Brazil on this subject, and there
is only one study investigating S65C in Brazilian patients
with HH.9 Thus, the aim of this work was to determine the
allelic frequencies of C282Y, H63D and S65C of the HFE gene
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Table 1
Genotype frequencies of HFE mutations in different population.
C282Y/
WT
C282Y/
C282Y
H63D/
WT
H63D/
H63D
C282Y/
H63D
H63D/
S65C
S65C/
WT
Our
Results 2.7% 0 18.3% 1.3% 0 0.7% 1.3%
Italy2 2.2% 0 20.9% 1.4% 0 - - - -
USA2 11.4% 1.0% 20.9% 2.9% 3.2% - - - -
Japan2 0 0 2.0% 0 0 - - - -
Africa2 0.2% 0 5.4% 0 0 - - - -
in healthy Brazilian individuals (blood donors) and in patients
with HH.
Material and methods
We analyzed blood samples of 148 healthy individuals
(blood donors) and 8 patients with clinical and laboratory
diagnoses of HH. Diagnosis of iron overload was achieved
using the elevated transferrin saturation index (≥ 55%) and
elevated serum ferritin concentration (≥ 500 ng/mL). Informed
consent was obtained from each individual included in this
study. The Ethics Committee of Unifesp approved the protocol
used in this investigation.
Human genomic DNA was extracted from peripheral
blood leukocytes; HFE mutations were detected by restriction
enzyme analysis of polymerase chain reaction-amplified DNA.
To detect the C282Y mutation, the forward primer 5'-
TGCCTCCTTTGGTGAAGGTGACAC-3' and reverse primer
5'-CTCAGGCACTCCTCTCAACC-3' were utilized.3,10 The
reactions were performed on a final volume of 25 µL
containing 2 mM MgCl2, 0.2 mM of each dNTP, 2 ng of
template DNA, 4 pmol of each primer and 1 U of Taq
Polymerase (Biotools) using the following sequence: 35 cycles
at 94ºC for 30 seconds, 67ºC for 30 seconds and 72ºC for 30
seconds and a final step at 72ºC for 5 minutes. The length of
the amplified fragment observed is 343 bp. After digestion
with Rsa I, the digested wild-type resulted in fragments of
203 and 140 bp, whereas the digested mutant produced
fragments of 203, 111 and 29 bp.
To detect the H63D and S65C mutations, the forward
primer 5'-TCACACTCTCTGCAGTACCTCTTCATGG-3' and
reverse primer 5'-TACACAGTGAACATGTGATCCCACC-3'
were utilized.10 The reactions were performed on a final volu-
me of 50 µ L containing 2 mM MgCl2, 0.2 mM of each dNTP,
2 ng of the DNA template, 2 pmol of each primer, and 1 U de
Taq Polymerase (Biotools) using the same thermal sequence
as described above. The length of the amplified fragment
observed is 223 bp.
For H63D detection, we digested it with Dpn II with
wild-type digestion resulting in fragments of 118 and 105 bp,
whereas mutant digestion showed only the 223 fragment.
For the S65C mutation, the Hinf I enzyme was utilized and
wild-type digestion resulted in fragments of 112, 69 and 42
bp, and the mutant digestion in fragments of 181 and 42 bp.
Results
Five HH patients (62.5%) presented with molecular
changes of the HFE gene: 3 were homozygous for the C282Y
mutation (C282Y/C282Y), one patient presented with a
compound heterozygous C282Y/H63D mutation and the fifth
patient was heterozygous for the C282Y mutation (C282Y/
WT). Three patients did not have any molecular changes.
Thus, the C282Y was the most frequent mutation in our group
of HH patients, corresponding to 8 of 16 (50%) of the alleles
analyzed.
The allelic frequencies of the 3 mutations in the blood
donor group were: 0.014 for the C282Y allele, 0.108 for H63D
and 0.010 for the S65C mutation. When we calculated the
genetic frequency for each mutation according to ethnic
origin, the C282Y mutation was found only in Caucasians
with an allelic frequency of 0.014. The H63D was seen in
Caucasians and African descendants with frequencies of
0.086 and 0.024, respectively. This difference was considered
significant (p=0.030). Only three S65C mutations were found:
2 (0.006) in Caucasians and 1 (0.003) in the African-Brazilian
group.
Discussion
There are few data on HH genotypes in Brazil, but all
showed different patterns to those found in northern
Europe.11,12 This difference can be explained by the Brazilian
ethnic miscegenation: predominant migration from southern
Europe, where mutations are less frequent, and a high
influence of Africans and Indians, populations that present
with low mutation rates.6,13,14
As shown in Table 1, our results demonstrated that
HFE genotypic frequencies in blood donors in São Paulo are
very close to those of the Italian population, in agreement to
the immigration observed in our state.2
The S65C mutation has not been investigated much
and there is little information about its genetic frequency. In
Spain and Italy its frequency is low.14,15 In a study of
Mediterranean populations a frequency of 0.15% was found
and in the United Kingdom it was 0.9%.16,17 We found that
the S65C genetic frequency in blood donors from São Paulo
is similar to the C282Y frequency (0.010), although in 35
Brazilian patients with iron overload the S65C mutation was
not observed.9 We consider these data relevant and
meritorious for further investigation due to the importance of
this mutation in iron overload according to the literature.18-20
Bittencourt et al.21 analyzed the HFE gene in 15 HH
patients and found 53% of C282Y homozygous and 7% of
heterozygous individuals. None had the compound
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heterozygous C282Y/H63D. Our results showed there were
37.5% of homozygous subjects for C282Y and 25% of
heterozygous individuals and one heterozygous with C282Y/
H63D.  Those data are different, maybe because both studies
involved a small number of patients (15 and 8, respectively).
Conclusion
The studies carried out in Brazil involving the HFE
gene, present the results of a small number of patients and
controls with this being the first investigation of the S65C
mutation in our general population. Because of our specific
racial miscegenation, we believe it is very important to perform
larger multi-center studies to define the genetic characteristics
of HH in Brazilian patients.
Resumo
A Hemocromatose hereditária (HH) é a alteração genética mais
comumente encontrada em descendentes de Europeus, em especial
da região Norte. A alteração clínica característica é a acúmulo
gradual do ferro em órgãos internos, que evolui para lesão orgâni-
ca e morte. Na maioria dos casos, o gene alterado é o HFE, que foi
identificado em 1996. Três variantes alélicas do gene HFE foram
correlacionados com a HH: a C282Y, significativamente associada
com a HH; e a H63D e a S65C, que apresentam uma relação
obscura com esta doença. Neste relato, foi analisada a presença
destas mutações em 8 pacientes com HH e em 148 indivíduos sau-
dáveis (doadores de sangue). Para detecção das mutações, foi rea-
lizado PCR dos exons 2 e 4 do gene HFE, seguido pela clivagem
com endonucleases específicas. No grupo de pacientes com HH,
observou-se 3 indivíduos homozigotos para a mutação de C282Y,
um heterozigoto composto (C282Y/H63D), um heterozigoto para
C282Y e ausência de mutações nos outros 3 pacientes. Nos indiví-
duos saudáveis, a freqüência observada foi de 0,014 para o alelo
C282Y, 0,108 para o H63D e 0,010 para o S65C. A presença de
mutações foi significantemente maior nos indivíduos brancos, com-
parando com os não brancos. Estes dados são concordantes com a
literatura prévia e com a origem étnica da população estudada.
Rev. bras. hematol. hemoter. 2006;28(4):293-295.
Palavras-chave: Gene HFE; polimorfismos; hemocromatose here-
ditária.
References
1. Pietrangelo A. Medical progress: Hereditary hemochromatosis -
a new look at an old disease. N Engl J Med 2004;350:2383-97.
2. Hanson EH, Imperatore G, Burke W. HFE gene and hereditary
hemochromatosis: A HuGE review. Am J Epidemiol 2001;154:
193-206.
3. Lyon E & Frank EL. Hereditary hemochromatosis since discovery
of HFE gene. Clinical Chesmistry 2001;47:1147-56.
Acknowledgments
This work was supported by grants from CNPq and FADA/
Unifesp.
4. Feder JN, Grinke A, Thomas W, et al. A novel MHC class I-like gene
is mutated in patients with hereditary haemochromatosis. Nat Genet
1996;13:399-408.
5. Beutler E. Hemochromatosis: Genetics and pathophysiology. Annu
Rev Med 2006;57:331-47.
6. Bomford A. Genetics of haemochromatosis. Lancet 2002;360:
1.673-81.
7. Wallace DF, Walker AP, Pietrangelo A, et al. Frequency of the
S65C mutation of HFE and iron overload in 309 subjects
heterozygous for C282Y. J Hepatol 2002;36:474-9.
8. Asberg A, Thorstensen K, Hveem K, et al. Hereditary hemo-
chromatosis: the clinical significance of the S65C mutation. Genet
Test 2002;6:59-62.
9. Cançado RD, Guglielmi ACO, Vergueiro CSV, et al. Analysis of
HFE gene mutations and HLA-A alleles in Brazilian patients with
iron overload. Sao Paulo Med J 2006;124(2):55-60.
10. Simonsen K, Dissing J, Rudbeck L, et al. Rapid and simple
determination hereditary haemochromatosis mutation by multiplex
PCR-SSCP: detection of a new polymorphic mutation. Ann Hum
Genet 1999;63:193-7.
11. Agostinho MF, Arruda VR, Basseres DS, et al.  Mutation analysis of
the HFE gene in Brazilian populations. Blood Cells Mol Dis 1999;
25:324-7.
12. Pereira AC, Mota GF, Krieger JF. Hemochromatosis gene variants
in three different ethnic populations: effects of admixture for
screening programs. Hum Biol 2002;73:145-51.
13. Curtin PD. The Atlantic slave trade: a census. University of
Wisconsin Press, Milwaukee, 1969
14. Remacha AF, Barcelo MJ, Sarda MP, et al. The S65C mutation in
Spain. Implications for iron overload screening. Haematologica
2000;85:1.324-5.
15. Candore G, Mantovani V, Balistreri CR, et al. Frequency of the
HFE gene mutations in five Italian populations. Blood Cells Mol
Dis 2002;29:267-73.
16. Campo S, Restuccia T, Villai D, et al. Analysis of haemochromatosis
gene mutations in a population from Mediterranean Basin. Liver
2001;21:233-6.
17. Jones DC, Young NT, Pigott C, et al. Comprehensive hereditary
hemochromatosis genotyping. Tissue Antigens 2002;60:481-8.
18. Beutler E, Felitti VJ, Koziol JA, et al. Penetrance of 845G A
(C282Y) HFE hereditary haemochromatosis mutation in the USA.
Lancet 2002;359:211-8.
19. Holmström P, Marmur J, Eggertsen G, et al. Mild iron overload in
patients carrying the HFE S65C gene mutation: a retrospective
study in patients with suspected iron overload and healthy controls.
Gut 2002;51:723-30.
20. Mura C, Raguenes O, Ferec C. HFE mutations analysis in 711
hemochromatosis probands: evidence for S65C implication in mild
form of hemochromatosis. Blood 1999;93:2502-5.
21. Bittencourt PL, Palácios SA, Couto CA, et al. Analysis of HLA-A
antigens and C282Y and H63D mutations of the HFE gene in
Brazilian patients with hemochromatosis. Braz J Med Biol Res
2002;35:329-35.
Avaliação: Editor e dois revisores externos
Conflito de interesse: não declarado
Recebido: 23/05/2006
Aceito: 14/08/2006
